Back
Atara Biotherapeutics Stock Price Chart
Top investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
36
ATRA
Atara Biotherapeutics
Last Price:
$6.84
Seasonality Move:
-3.05%
7 Day Trial
ALL ACCESS PASS
$
7
Spencer Rascoff co-founded Zillow, scaling it to a $16B valuation. But everyday investors couldn't invest until the IPO, missing early gains.
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ATRA is experiencing slight buying pressure.
Atara Biotherapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 7.12 | Buy |
| 20-day SMA: | 7.17 | Buy |
| 50-day SMA: | 6.69 | Buy |
| 200-day SMA: | 8.82 | Sell |
| 8-day EMA: | 7.11 | Buy |
| 20-day EMA: | 7.04 | Buy |
| 50-day EMA: | 7.14 | Buy |
| 200-day EMA: | 10.2 | Sell |
Atara Biotherapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.11 | Buy |
| Relative Strength Index (14 RSI): | 56.6 | Buy |
| Chaikin Money Flow: | 43200 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (6.12 - 7.64) | Buy |
| Bollinger Bands (100): | (5.49 - 11.21) | Sell |
Atara Biotherapeutics Technical Analysis
| May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 02 | 05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Atara Biotherapeutics Stock
Is Atara Biotherapeutics Stock a Buy?
-
Atara Biotherapeutics share price is 7.61 while ATRA 8-day simple moving average is 7.12, which is a Buy signal.
-
The stock price of ATRA is 7.61 while Atara Biotherapeutics 20-day SMA is 7.17, which makes it a Buy.
-
Atara Biotherapeutics 50-day simple moving average is 6.69 while ATRA share price is 7.61, making it a Buy technically.
-
ATRA stock price is 7.61 and Atara Biotherapeutics 200-day simple moving average is 8.82, creating a Sell signal.
ATRA Technical Analysis vs Fundamental Analysis
Sell
36
Atara Biotherapeutics (ATRA)
is a Sell
Is Atara Biotherapeutics a Buy or a Sell?
-
Atara Biotherapeutics stock is rated a SellThe current Atara Biotherapeutics [ATRA] share price is $7.61. The Score for ATRA is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
Atara Biotherapeutics Stock Info
Market Cap:
45.4M
Price in USD:
7.61
Share Volume:
191.8K
Atara Biotherapeutics 52-Week Range
52-Week High:
18.71
52-Week Low:
5.01
Sell
36
Atara Biotherapeutics (ATRA)
is a Sell
Atara Biotherapeutics Share Price Forecast
-
What is the Atara Biotherapeutics stock price today?The Atara Biotherapeutics stock price is 7.61 USD today.
-
Will ATRA stock go up or go down?Atara Biotherapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Atara Biotherapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Atara Biotherapeutics is overvalued.
Is Atara Biotherapeutics Stock a Buy?
-
Atara Biotherapeutics share price is 7.61 while ATRA 8-day exponential moving average is 7.11, which is a Buy signal.
-
The stock price of ATRA is 7.61 while Atara Biotherapeutics 20-day EMA is 7.04, which makes it a Buy.
-
Atara Biotherapeutics 50-day exponential moving average is 7.14 while ATRA share price is 7.61, making it a Buy technically.
-
ATRA stock price is 7.61 and Atara Biotherapeutics 200-day simple moving average is 10.20, creating a Sell signal.
Fundamental Analysis of Atara Biotherapeutics
Is Atara Biotherapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $3.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.51 per share, and a decrease next year of $2.47 per share.
Technical Analysis of Atara Biotherapeutics
Should I short Atara Biotherapeutics stock?
-
ATRA Moving Average Covergence Divergence (MACD) indicator is 0.11, suggesting Atara Biotherapeutics is a Buy
-
Atara Biotherapeutics Relative Strength Index (RSI) is 56.6, which suggest Atara Biotherapeutics is overbought
-
The Bollinger Bands (25) for Atara Biotherapeutics is (6.12 - 7.64), which suggest Atara Biotherapeutics is a Sell
-
The Bollinger Bands (100) for Atara Biotherapeutics is (5.49 - 11.21), which suggest Atara Biotherapeutics is a Sell
* Atara Biotherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.